The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2025
Filed:
Mar. 31, 2021
Applicant:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Inventors:
Zacharia Cheruvallath, San Diego, CA (US);
Jason Green, San Diego, CA (US);
Kristin Schleicher, San Diego, CA (US);
Huikai Sun, San Diego, CA (US);
Mingnam Tang, San Diego, CA (US);
Assignee:
TAKEDA PHARMACEUTICAL COMPANY LIMITED, Osaka, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); A61K 45/06 (2013.01); C07D 401/12 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07B 2200/07 (2013.01);
Abstract
Disclosed are compounds of Formula (1), and pharmaceutically acceptable salts thereof, wherein n, R, R, R, R, R, R, R, R, R, R, X, Xand Xare defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula (1), to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders, and conditions associated with SSTR4.